The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.
A recent study published in Public Health Management & Practice found that, based on projected numbers of severe pediatric cases of coronavirus disease 2019 (COVID-19) in the United States, a surge in pediatric COVID-19 cases would result in “unique challenges” and possible resource strain for pediatric intensive care units (PICUs).1
The empirical case projection study calculated estimated rates of children infected with COVID-19 in the United States, in addition to projected cumulative numbers of children severely ill with the virus and needing to be hospitalized.1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has infected more than 1,094,000 Americans, and over 3,329,000 worldwide.2
Seventy-four children were reportedly admitted to PICUs in 19 states by April 6. According to the study, this rate reflects approximately 176,190 children in total infected with the virus (52,381 infants and toddlers younger than 2; 42, 859 children ages 2 to 11; and 80,952 children between the ages of 12 and 17).
Proportions for adjusted pediatric severity and adjusted pediatric criticality came from clinical and spatiotemporal modeling studies of SARS-CoV-2 when it spread through China between January and February 2020.1
Estimates of total COVID-19 pediatric infections in the United States were determined by US pediatric intensive care unit (PICU) cases and the adjusted pediatric criticality proportion. Investigators created the projected numbers of severely and critically ill children through the application of adjusted severity and criticality proportions to population data in the United States, under various scenarios and combined pediatric infection proportion (CPIP).
Applying a CPIP scenario of 5% would result in an estimated 3.7 million pediatric infections, 2997 children severely ill and needing to be hospitalized, and 1086 pediatric patients critically ill and needing treatment at a PICU.1
Even in moderate CPIP scenarios, the number of pediatric cases could overextend PICU resources, according to the study.1
1. EB Pathak, JP Salemi, N Sobers, et al. COVID-19 in Children in the United States. Journal of Public Health Management and Practice. 2020; doi: 10.1097/PHH.0000000000001190.
2. Coronavirus Resource Center. Johns Hopkins University & Medicine. https://coronavirus.jhu.edu/us-map. Accessed May 1, 2020.
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.